FDA limits use of the J&J Janssen COVID-19 vaccine

The U.S. Food and Drug Administration has limited the use of the  Johnson & Johnson Janssen COVID-19 vaccine due to rare blood clotting instances of thrombosis with thrombocytopenia syndrome (TTS) after receiving the vaccine.

Read the full post at News Feed
Vote This Post DownVote This Post Up (No Ratings Yet)
Explore the Archive